Aurobindo Pharma informs about board meeting

27 Oct 2023 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Thursday, November 9, 2023, to consider and approve the following: Standalone & Consolidated Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2023 and payment of Interim Dividend, if any, for the financial year 2023-24. Further to its letter dated September 27, 2023, informing about the closure of Trading Window of the Company from October 1, 2023, until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2023, the company has informed that the Trading Window will remain closed up to November 11, 2023, and shall be re-opened on November 12, 2023.

The above information is a part of company’s filings submitted to BSE.


Aurobindo Pharma Share Price

1131.80 28.25 (2.56%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.